Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | September 08, 2023 01:31pm

Gainers

  • Biocept (NASDAQ:BIOC) shares increased by 59.4% to $1.34 during Friday's regular session. Trading volume for this security as of 13:30 EST is 92.7 million, which is 55919.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.5 million.
  • Axcella Health (NASDAQ:AXLA) stock moved upwards by 46.3% to $0.84. Trading volume for Axcella Health's stock is 86.3 million as of 13:30 EST. This is 674.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $61.9 million.
  • Myomo (AMEX:MYO) shares increased by 21.94% to $1.12. Trading volume for this security as of 13:30 EST is 928.0K, which is 210.0% of its average full-day volume over the last 100 days. The company's market cap stands at $29.6 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) stock increased by 19.51% to $0.71. The current volume of 418.3K shares is 451.4% of Lucy Scientific Discovery's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $12.2 million.
  • Atossa Therapeutics (NASDAQ:ATOS) stock rose 19.34% to $0.89. Trading volume for Atossa Therapeutics's stock is 1.0 million as of 13:30 EST. This is 120.8% of its average full-day volume over the last 100 days. The company's market cap stands at $111.6 million.
  • Aesthetic Medical Intl (NASDAQ:AIH) shares rose 16.12% to $0.82. As of 13:30 EST, Aesthetic Medical Intl's stock is trading at a volume of 128.1K, which is 804.3% of its average full-day volume over the last 100 days. The company's market cap stands at $35.6 million. As per the news, the H1 earnings report came out 3 days ago.

Losers

  • Plus Therapeutics (NASDAQ:PSTV) shares declined by 29.3% to $2.1 during Friday's regular session. Trading volume for Plus Therapeutics's stock is 3.6 million as of 13:30 EST. This is 8567.7% of its average full-day volume over the last 100 days. The company's market cap stands at $6.0 million.
  • NeuBase Therapeutics (NASDAQ:NBSE) shares decreased by 20.86% to $1.48. The current volume of 1.7 million shares is 83.9% of NeuBase Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $4.6 million.
  • Ekso Bionics Holdings (NASDAQ:EKSO) shares fell 18.96% to $0.73. Ekso Bionics Holdings's stock is trading at a volume of 247.4K shares as of 13:30 EST. This is 571.0% of its average full-day volume over the last 100 days. The company's market cap stands at $10.1 million.
  • Allarity Therapeutics (NASDAQ:ALLR) shares declined by 17.15% to $1.16. The current volume of 255.6K shares is 33.3% of Allarity Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $3.1 million.
  • Trevena (NASDAQ:TRVN) stock decreased by 13.93% to $0.68. Trading volume for this security as of 13:30 EST is 1.4 million, which is 225.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.3 million.
  • Tempest Therapeutics (NASDAQ:TPST) shares declined by 13.49% to $0.4. The current volume of 107.9K shares is 93.0% of Tempest Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $5.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIH ALLR ATOS AXLA BIOC EKSO LSDI MYO NBSE PSTV TPST TRVN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist